Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment
Authors
Keywords
-
Journal
GUT
Volume 63, Issue 10, Pages 1668-1676
Publisher
BMJ
Online
2014-07-23
DOI
10.1136/gutjnl-2014-307323
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma
- (2014) Bhavna Rani WORLD JOURNAL OF GASTROENTEROLOGY
- Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models
- (2013) D. Siolas et al. CANCER RESEARCH
- A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer
- (2013) A. X. Zhu et al. CLINICAL CANCER RESEARCH
- A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection
- (2013) Jean–Charles Nault et al. GASTROENTEROLOGY
- Keratin 19: a key role player in the invasion of human hepatocellular carcinomas
- (2013) Olivier Govaere et al. GUT
- Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma
- (2013) Laurent Sulpice et al. HEPATOLOGY
- Transforming Growth Factor-β (TGF-β)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling Activation
- (2013) Yan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
- (2013) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
- (2013) Josep M. Llovet et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting the NF-κB Pathway in Cancer Therapy
- (2013) Derek J. Erstad et al. Surgical Oncology Clinics of North America
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
- (2012) R. S. Finn et al. CLINICAL CANCER RESEARCH
- Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma
- (2012) Wolfgang Sieghart et al. JOURNAL OF HEPATOLOGY
- Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
- (2012) Armando Santoro et al. LANCET ONCOLOGY
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hepatic stellate cells stimulate HCC cell migration via laminin-5 production
- (2011) Angela Santamato et al. CLINICAL SCIENCE
- MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a
- (2011) Sara Toffanin et al. GASTROENTEROLOGY
- Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
- (2011) Massimo Iavarone et al. HEPATOLOGY
- PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma
- (2011) Francesco Dituri et al. INTERNATIONAL JOURNAL OF CANCER
- Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study
- (2010) Emilia Fransvea et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review
- (2010) Ketao Jin et al. Clinical & Translational Oncology
- Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
- (2010) K.-F. Chen et al. CLINICAL CANCER RESEARCH
- Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases
- (2010) Olav A. Gressner et al. LIVER INTERNATIONAL
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Expression of Autotaxin and Lysophosphatidic Acid Receptors Increases Mammary Tumorigenesis, Invasion, and Metastases
- (2009) Shuying Liu et al. CANCER CELL
- Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
- (2009) Y. Hoshida et al. CANCER RESEARCH
- Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
- (2009) Mei-Hwei Chang et al. JNCI-Journal of the National Cancer Institute
- Dysregulation of apoptosis in hepatocellular carcinoma cells
- (2009) Isabel Fabregat WORLD JOURNAL OF GASTROENTEROLOGY
- TRAIL-induced apoptosis of hepatocellular carcinoma cells isaugmented by targeted therapies
- (2009) Bruno Christian Koehler et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Microvascular Invasion in Patients with Hepatocellular Carcinoma and Its Predictable Clinicopathological Factors
- (2008) Shuji Sumie et al. ANNALS OF SURGICAL ONCOLOGY
- Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
- (2008) D. Y. Chiang et al. CANCER RESEARCH
- Direct In Vivo Xenograft Tumor Model for Predicting Chemotherapeutic Drug Response in Cancer Patients
- (2008) B Rubio-Viqueira et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004
- (2008) Cristina Bosetti et al. HEPATOLOGY
- Transforming growth factor-β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer
- (2008) Cédric Coulouarn et al. HEPATOLOGY
- Connective tissue growth factor (CTGF) and cancer progression
- (2008) Chia-Yu Chu et al. JOURNAL OF BIOMEDICAL SCIENCE
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
- (2008) Yujin Hoshida et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started